BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32727411)

  • 21. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
    Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J
    Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral orbital involvement of IgG4-related disease detected on 18F-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: A Clinical Case Report.
    Dong P; Wang L; Li L
    Medicine (Baltimore); 2019 Nov; 98(47):e18138. PubMed ID: 31764855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of Flow Cytometry in Diagnosis of IgG4-Related Ophthalmic Disease and Extranodal Marginal Zone B-Cell Lymphoma of the Ocular Adnexa.
    Kase S; Ishijima K; Uraki T; Suimon Y; Suzuki Y; Kase M; Ishida S
    Anticancer Res; 2017 Sep; 37(9):5001-5004. PubMed ID: 28870925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.
    Huang H; Xiao F; Han X; Zhong L; Zhong H; Xu L; Zhu J; Ni B; Liu J; Fang Y; Zhang M; Shen L; Wang T; Liu J; Shi Y; Chen Y; Zheng L; Liu Q; Chen F; Wang J
    Nucl Med Commun; 2016 Jul; 37(7):689-98. PubMed ID: 27244584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular/perivascular inflammation in IgG4-related disease.
    Imai S; Tahara N; Igata S; Tahara A; Bekki M; Sugiyama Y; Maeda-Ogata S; Honda A; Otsuka H; Ushijima T; Okabe Y; Kaida H; Abe T; Tanaka H; Fukumoto Y; Tayama E
    J Nucl Cardiol; 2022 Dec; 29(6):2920-2933. PubMed ID: 34704218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thoracic Hyper-IgG4-Related Disease Mimicking Malignant Pleural Mesothelioma.
    Lococo F; Di Stefano T; Rapicetta C; Piro R; Gelli MC; Muratore F; Ricchetti T; Taddei S; Zizzo M; Cesario A; Facciolongo N; Paci M
    Lung; 2019 Jun; 197(3):387-390. PubMed ID: 30941506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual presentation of extranodal diffuse large B-cell lymphoma in a solid-organ recipient during long-term immunosuppressive treatment.
    Camerini C; Sant'Antonio E; Ginori A; Pellegri M; De Gaudio C; Banti E; Ciliberti V; Parrini M; Bozzoli L; Simonetti F; Capochiani E
    Tumori; 2021 Dec; 107(6):NP127-NP130. PubMed ID: 34423702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin G4-Related Disease Manifesting as Isolated, Typical, and Nontypical Gastroesophageal Lesion: A Research of Literature Review.
    Khan S; Zhu LP; Jiang K; Liu W; Chen X; Wang BM
    Digestion; 2020; 101(5):506-521. PubMed ID: 31291621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of IgG4-related Disease with Crescentic Glomerulonephritis: An Unusual Presentation of the Disease.
    Ghaffari A; Mehrazma M; Ossareh S
    Iran J Kidney Dis; 2024 Mar; 18(2):133-135. PubMed ID: 38660697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An IgA1-lambda-type monoclonal immunoglobulin deposition disease associated with membranous features in a patient with IgG4-related kidney disease: a case report.
    Kitazawa A; Koda R; Yoshino A; Ueda Y; Takeda T
    BMC Nephrol; 2018 Nov; 19(1):330. PubMed ID: 30458736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of
    Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J
    Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin G4-related disease: case report and literature review.
    Dong LL; Sheikh IS; Huang AH; Wu XH; Chen EG; Ying KJ
    Immunol Res; 2021 Oct; 69(5):415-421. PubMed ID: 34374950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.
    Adams HJ; Nievelstein RA; Kwee TC
    Br J Haematol; 2015 Jul; 170(2):185-91. PubMed ID: 25833790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
    Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
    Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
    Tateishi U; Tatsumi M; Terauchi T; Ando K; Niitsu N; Kim WS; Suh C; Ogura M; Tobinai K
    Cancer Sci; 2015 Feb; 106(2):186-93. PubMed ID: 25495273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of IgG4-related interstitial nephritis with ureteral obstruction: case report and literature review.
    Cai XQ; Chen ZB; Chen HH; Zheng YQ; Yu XG
    BMC Urol; 2023 Apr; 23(1):67. PubMed ID: 37118801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
    Lavi N; Shapira G; Zilberlicht A; Benyamini N; Farbstein D; Dann EJ; Bar-Shalom R; Avivi I
    Isr Med Assoc J; 2016 Jul; 18(7):411-417. PubMed ID: 28471564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG4-related lung disease with recurrent pulmonary lesions during steroid therapy and difficulty in differentiating from malignancy: a case report.
    Okubo T; Nakashima N; Tokunaga Y; Kita N; Nakamura H; Ishikawa R; Okada S; Go T; Yokomise H
    J Cardiothorac Surg; 2022 Apr; 17(1):62. PubMed ID: 35365166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
    de Oliveira Costa R; Hallack Neto A; Siqueira S; Lage LA; de Paula HM; Coutinho AM; Pereira J
    Nucl Med Commun; 2016 Oct; 37(10):1095-101. PubMed ID: 27281359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.